EWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors.
作者信息
Torzilli Guido, Vauthey Jean-Nicolas, Belghiti Jacques, Makuuchi Masatoshi, Donadon Matteo, Viganò Luca, Kokudo Norihiro
机构信息
Department of Surgery, Division of Hepatobiliary and General Surgery, Humanitas University, Hu-manitas Research Hospital, Milan, Italy.
Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Tex. USA.
出版信息
Liver Cancer. 2016 Nov;6(1):13-15. doi: 10.1159/000449494. Epub 2016 Nov 29.
Abstract
摘要
相似文献
1
EWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors.EWALT：东西方在多学科环境中相遇，以改善肝脏肿瘤的管理。
Liver Cancer. 2016 Nov;6(1):13-15. doi: 10.1159/000449494. Epub 2016 Nov 29.
2
COVID-19 and liver surgery in France, Italy, Japan, and the United States: A report of a single topic conference of Eastern and Western Association for Liver Tumors (EWALT) 2021.法国、意大利、日本和美国的新冠肺炎与肝脏手术：东西方肝脏肿瘤协会（EWALT）2021年单一主题会议报告
Glob Health Med. 2021 Aug 31;3(4):240-242. doi: 10.35772/ghm.2021.01062.
3
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west.肝细胞癌合并门静脉癌栓患者的管理：东西比较。
Lancet Gastroenterol Hepatol. 2019 Sep;4(9):721-730. doi: 10.1016/S2468-1253(19)30178-5.
4
Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West.对比东西方在治疗不可切除的晚期肝细胞癌方面的差异。
Clin Oncol (R Coll Radiol). 2019 Aug;31(8):560-569. doi: 10.1016/j.clon.2019.06.002.
5
Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.真实世界临床实践中治疗晚期肝细胞癌：东西交汇。
PLoS One. 2020 Mar 12;15(3):e0230005. doi: 10.1371/journal.pone.0230005. eCollection 2020.
6
East meets the West--portal pressure predicts outcome of surgical resection for hepatocellular carcinoma.东西方碰撞——门静脉压力可预测肝细胞癌手术切除的预后
Nat Clin Pract Gastroenterol Hepatol. 2009 Jan;6(1):14-5. doi: 10.1038/ncpgasthep1300. Epub 2008 Nov 4.
7
[Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].[日本与西方国家肝细胞癌临床实践指南的比较]
Nihon Geka Gakkai Zasshi. 2008 Nov;109(6):343-8.
8
East meets West: East and West pioneers of "anatomical right hepatectomy" - period of dawn to establishment.东西方交汇：“解剖性右肝切除术”的东西方先驱——从萌芽到确立的时期
J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):214-216. doi: 10.1002/jhbp.531.
9
Reply to Letter: "A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group": When the Study Setting "Ignores" the Patients.对信件的回复：“三级转诊中心肝细胞癌手术的有效指征及结果概览：是否符合欧洲肝脏研究学会/美国肝病研究学会的建议？肝癌东西方研究组的一项观察性研究”：当研究背景“忽略”患者时
Ann Surg. 2015 Jul;262(1):e30-1. doi: 10.1097/SLA.0000000000000382.
10
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study.拥有多学科团队的心脏移植中心在慢性病管理方面表现出更高水平——国际BRIGHT研究的结果。
Heart Lung. 2017 Sep-Oct;46(5):351-356. doi: 10.1016/j.hrtlng.2017.05.006. Epub 2017 Jun 16.
引用本文的文献
1
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.结直肠肝转移瘤切除术：一项调查外科医生发病率、临床影响及处理方式的调查。
J Gastrointest Surg. 2018 Oct;22(10):1752-1763. doi: 10.1007/s11605-018-3820-z. Epub 2018 Jun 8.
本文引用的文献
1
Early survival and safety of ALPPS: first report of the International ALPPS Registry.联合肝脏离断和门静脉结扎的二步肝切除术（ALPPS）的早期生存和安全性：国际 ALPPS 注册中心的首次报告。
Ann Surg. 2014 Nov;260(5):829-36; discussion 836-8. doi: 10.1097/SLA.0000000000000947.
2
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
3
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.西妥昔单抗新辅助化疗后结直肠癌肝转移的肿瘤反应和二次可切除性：CELIM 随机 2 期试验。
Lancet Oncol. 2010 Jan;11(1):38-47. doi: 10.1016/S1470-2045(09)70330-4. Epub 2009 Nov 26.
4
Sorafenib in advanced hepatocellular carcinoma.索拉非尼用于晚期肝细胞癌
N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.
5
Proceedings of the Fifth International Meeting, Hepatocellular Carcinoma: Eastern and Western Experiences Overview of the Conference.
Ann Surg Oncol. 2008 Apr;15(4):961. doi: 10.1245/s10434-007-9726-8. Epub 2008 Jan 31.
6
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature.肝移植患者新发乳腺癌：匹兹堡大学的经验及文献综述
Liver Transpl. 2004 Jan;10(1):1-6. doi: 10.1002/lt.20025.
7
Hepatocellular Carcinoma: Eastern and Western Experiences. Proceedings of an international congress. Tokyo, Japan, December 9, 2000.肝细胞癌：东西方经验。国际大会会议记录。日本东京，2000年12月9日。
Hepatogastroenterology. 2002 Jan-Feb;49(43):5-95.
8
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.不可切除肝细胞癌患者的动脉栓塞或化疗栓塞与对症治疗对比：一项随机对照试验
Lancet. 2002 May 18;359(9319):1734-9. doi: 10.1016/S0140-6736(02)08649-X.
9
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.经动脉碘油化疗栓塞术治疗不可切除肝细胞癌的随机对照试验
Hepatology. 2002 May;35(5):1164-71. doi: 10.1053/jhep.2002.33156.
Zotero 插件